Elite Pharma Valuation
| ELTPDelisted Stock | USD 0.04 0 6.75% |
Elite Pharma seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Elite Pharma from reviewing the firm fundamentals such as Current Valuation of 27.92 M, profit margin of 0.20 %, and Shares Outstanding of 1.01 B as well as analyzing its technical indicators and probability of bankruptcy. . In general, most investors advise buying undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.
Overvalued
Today
Please note that Elite Pharma's price fluctuation is very steady at this time. Calculation of the real value of Elite Pharma is based on 3 months time horizon. Increasing Elite Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Elite otc stock is determined by what a typical buyer is willing to pay for full or partial control of Elite Pharma. Since Elite Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Elite OTC Stock. However, Elite Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0373 | Real 0.0313 | Hype 0.04 | Naive 0.0337 |
The intrinsic value of Elite Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Elite Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Elite Pharma helps investors to forecast how Elite otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Elite Pharma more accurately as focusing exclusively on Elite Pharma's fundamentals will not take into account other important factors: Elite Pharma Total Value Analysis
Elite Pharma is currently anticipated to have valuation of 27.92 M with market capitalization of 38.53 M, debt of 1.39 M, and cash on hands of 19.78 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Elite Pharma fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
27.92 M | 38.53 M | 1.39 M | 19.78 M |
Elite Pharma Investor Information
About 18.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.12. Some equities with similar Price to Book (P/B) outperform the market in the long run. Elite Pharma had not issued any dividends in recent years. Based on the key measurements obtained from Elite Pharma's financial statements, Elite Pharma is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Elite Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Elite Pharma has an asset utilization ratio of 91.79 percent. This connotes that the OTC Stock is making $0.92 for each dollar of assets. An increasing asset utilization means that Elite Pharma is more efficient with each dollar of assets it utilizes for everyday operations.Elite Pharma Ownership Allocation
Elite Pharma holds a total of 1.01 Billion outstanding shares. Elite Pharma shows 17.53 percent of its outstanding shares held by insiders and 0.057 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Elite Pharma Profitability Analysis
The company reported the previous year's revenue of 32.26 M. Net Income was 8.9 M with profit before overhead, payroll, taxes, and interest of 14.8 M.About Elite Pharma Valuation
The otc valuation mechanism determines Elite Pharma's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Elite Pharma based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Elite Pharma. We calculate exposure to Elite Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Elite Pharma's related companies.Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey. Elite Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 43 people.
8 Steps to conduct Elite Pharma's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Elite Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Elite Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Elite Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Elite Pharma's revenue streams: Identify Elite Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Elite Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Elite Pharma's growth potential: Evaluate Elite Pharma's management, business model, and growth potential.
- Determine Elite Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Elite Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Elite Pharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as Elite Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1 B | |
| Quarterly Earnings Growth Y O Y | 0.098 | |
| Retained Earnings | -140.1 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Elite OTC Stock
If you are still planning to invest in Elite Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Elite Pharma's history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |